UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

Spring Bank Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

849431101

(CUSIP Number)

November 23, 2016

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

SEC 1745(3-06)

 

Page 1 of 11 pages


CUSIP No. 849431101  

 

  1.  

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

 

Peter Lacaillade Jr.

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)   ¨         (b)   ¨

 

  3.  

SEC Use Only

 

  4.  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

724,848

   6.   

Shared Voting Power

 

15,762

   7.   

Sole Dispositive Power

 

724,848

   8.   

Shared Dispositive Power

 

15,762

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

740,610

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

7.9%

12.  

Type of Reporting Person (See Instructions)

 

IN

 

 

Page 2 of 11 pages


CUSIP No. 849431101  

 

  1.  

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

 

The E. Burke Ross, Jr. Descendants’ GST Insurance Trust

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)   ¨         (b)   ¨

 

  3.  

SEC Use Only

 

  4.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

0

   6.   

Shared Voting Power

 

0

   7.   

Sole Dispositive Power

 

0

   8.   

Shared Dispositive Power

 

0

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

148,605

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

1.6%

12.  

Type of Reporting Person (See Instructions)

 

OO

 

 

Page 3 of 11 pages


CUSIP No. 849431101  

 

  1.  

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

 

The E. Burke Ross, Jr. Descendants’ GST Investment Trust 2014

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)   ¨         (b)   ¨

 

  3.  

SEC Use Only

 

  4.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

0

   6.   

Shared Voting Power

 

0

   7.   

Sole Dispositive Power

 

0

   8.   

Shared Dispositive Power

 

0

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

576,243

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

6.1%

12.  

Type of Reporting Person (See Instructions)

 

OO

 

 

Page 4 of 11 pages


CUSIP No. 849431101  

 

  1.  

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

 

Susan Lutz Ross Family Insurance Trust

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)   ¨         (b)   ¨

 

  3.  

SEC Use Only

 

  4.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

0

   6.   

Shared Voting Power

 

15,762

   7.   

Sole Dispositive Power

 

0

   8.   

Shared Dispositive Power

 

15,762

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

15,762

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

0.2%

12.  

Type of Reporting Person (See Instructions)

 

OO

 

 

Page 5 of 11 pages


Item 1.

 

  (a) Name of Issuer

 

  The name of the issuer is Spring Bank Pharmaceuticals, Inc.

 

  (b) Address of Issuer’s Principal Executive Officer

 

  The issuer’s principal executive offices are located at 86 South Street, Hopkinton MA 01748

Item 2.

 

  (a) Name of Person Filing

 

    Peter Lacaillade Jr.

 

    The E. Burke Ross, Jr. Desendants’ GST Insurance Trust

 

    The E. Burke Ross, Jr. Descendants’ GST Investment Trust 2014

 

    Susan Lutz Ross Family Insurance Trust

 

  (b) Address of Principal Business Office or, if none, Residence

The principal business address for The E. Burke Ross, Jr. Descendants’ GST Insurance Trust and The E. Burke Ross, Jr. Descendants’ GST Investment Trust 2014 is C/O JDJ Family Office Services, PO BOX 962409, Boston, MA 02196.

The principal business address for the Susan Lutz Ross Family Insurance Trust is C/O ADEC Private Equity Investments LLC, 172 S. Ocean Blvd., Palm Beach, FL 33480.

 

  (c) Citizenship

Peter Lacaillade Jr. is a United States citizen.

The E. Burke Ross, Jr. Descendants’ GST Insurance Trust and The E. Burke Ross, Jr. Descendants’ GST Investment Trust 2014 are Delaware trusts.

The Susan Lutz Ross Family Insurance Trust is a Delaware trust.

 

  (d) Title of Class of Securities

Common Stock, $0.0001 per share (the “Common Stock”)

 

  (e) CUSIP Number

849431101

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

  (a) ¨      Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 

  (b) ¨      Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 

  (c) ¨      Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 

  (d) ¨      Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

 

  (e) ¨      An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

  (f) ¨      An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

  (g) ¨      A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

 

  (h) ¨      A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

  (i) ¨      A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment          Company Act of 1940 (15 U.S.C. 80a-3);

 

Page 6 of 11 pages


  (j) ¨      Group, in accordance with §240.13d-1(b)(1)(ii)(J).

Item 4. Ownership.

The information required by Items 4(a) – (c) is set forth in Rows (5)–(11) on the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The Issuer’s Quarterly Report on Form 10-K for the quarter ended September 30, 2016, filed on October 28, 2016, indicates that as of October 27, 2016, the Issuer had 7,767,981 shares of common stock outstanding and the Issuer’s Current Report on Form 8-K, filed on November 21, 2016, states that the Issuer has issued and sold an aggregate of 1,644,737 additional shares of common stock. The percentages set forth in Row (11) of the cover page for each Reporting Person is based on these numbers, and the shares of common stock reported for the E. Burke Ross Jr. Descendants’ GST Investment Trust 2014 includes 26,455 shares of common stock underlying warrants.

Item 5. Ownership of Five Percent or Less of a Class

Not applicable

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not applicable

Item 8. Identification and Classification of Members of the Group See Item 2 (a)-(c)

Not applicable

Item 9. Notice of Dissolution of Group

Not applicable

Item 10. Certification

Each of the Reporting Persons hereby makes the following Certification:

 

 

Page 7 of 11 pages


By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

12/5/16

Date

 

/s/ Peter Lacaillade Jr.

Signature

Peter Lacaillade Jr., Individually

Name/Title

 

Page 8 of 11 pages


By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

THE E. BURKE ROSS, JR. DESCENDANTS’ GST INSURANCE TRUST

 

12/5/16

 

Date

 

/s/ Peter Lacaillade Jr.

Signature

Peter Lacaillade Jr., as Trustee

Name/Title

 

Page 9 of 11 pages


By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

THE E. BURKE ROSS, JR. DESCENDANTS’ GST INVESTMENT TRUST 2014

 

12/5/16

 

Date

 

/s/ Peter Lacaillade Jr.

Signature

Peter Lacaillade Jr., as Trustee

Name/Title

 

Page 10 of 11 pages


By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

SUSAN LUTZ ROSS FAMILY INSURANCE TRUST

 

12/5/16

 

Date

 

/s/ Peter Lacaillade Jr.

Signature

Peter Lacaillade Jr., as Trustee

Name/Title

 

Page 11 of 11 pages

Spring Bank Pharmaceutic... (NASDAQ:SBPH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Spring Bank Pharmaceutic... Charts.
Spring Bank Pharmaceutic... (NASDAQ:SBPH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Spring Bank Pharmaceutic... Charts.